Rapid infusion of hyperosmolar solutions into the internal carotid artery transiently disrupts the blood-brain barrier, permitting entry of substances that are ordinarily excluded from the nervous system. This study compared gentamicin concentrations in the cerebrospinal fluid (CSF) and brain tissue of rabbits receiving intracarotid infusions of 2 molal mannitol with those in three groups of control animals. After catheter placement and intravenous gentamicin administration (20 mg/kg), rabbits received either 2 molal mannitol in the internal carotid artery, 2 molal mannitol intravenously, 0.9%o saline in the internal carotid artery, or 0.9%o saline intravenously. Mannitol and saline were administered in 8-ml bolus injections over 40 s. After 2 h, serum, CSF, and brain specimens were obtained for antibiotic assay, Gentamicin concentrations in serum were comparable in all groups (mean concentrations ranged from 14.6 to 17.9 ,ug/ml at 60 min and from 5.7 to 7.4 g/ml at 135 min), but gentamicin concentrations in CSF and brains were significantly higher in animals in the group receiving mannitol in the internal carotid artery. In this group the mean gentamicin concentration in CSF, 5.3 ,ug/ml, was twofold greater than those in the other three groups (range, 1.7 to 2.6 ,ug/ml). Similarly, the mean gentamicin concentration in the brains of animals in the group receiving mannitol in the internal carotid artery, 2.3 ,ug/g was significantly higher than those in the other groups (mean of measurable values, 1.4 pug/g, in all three control groups). Osmotic disruption of the blood-brain barrier enhanced the penetration of gentamicin into CSF and brain tissue.
Rapid infusion of hyperosmolar solutions into the internal carotid artery transiently disrupts the blood-brain barrier, permitting entry of substances that are ordinarily excluded from the nervous system. This study compared gentamicin concentrations in the cerebrospinal fluid (CSF) and brain tissue of rabbits receiving intracarotid infusions of 2 molal mannitol with those in three groups of control animals. After catheter placement and intravenous gentamicin administration (20 mg/kg), rabbits received either 2 molal mannitol in the internal carotid artery, 2 molal mannitol intravenously, 0.9%o saline in the internal carotid artery, or 0.9%o saline intravenously. Mannitol and saline were administered in 8-ml bolus injections over 40 s. After 2 h, serum, CSF, and brain specimens were obtained for antibiotic assay, Gentamicin concentrations in serum were comparable in all groups (mean concentrations ranged from 14.6 to 17.9 ,ug/ml at 60 min and from 5.7 to 7.4 g/ml at 135 min), but gentamicin concentrations in CSF and brains were significantly higher in animals in the group receiving mannitol in the internal carotid artery. In this group the mean gentamicin concentration in CSF, 5.3 ,ug/ml, was twofold greater than those in the other three groups (range, 1.7 to 2.6 ,ug/ml). Similarly, the mean gentamicin concentration in the brains of animals in the group receiving mannitol in the internal carotid artery, 2.3 ,ug/g was significantly higher than those in the other groups (mean of measurable values, 1.4 pug/g, in all three control groups). Osmotic disruption of the blood-brain barrier enhanced the penetration of gentamicin into CSF and brain tissue.
Rapoport has described a novel technique that transiently disrupts the integrity of the mammalian blood-brain barrier. The technique involves infusions of hyperosmolar solutions into the internal carotid artery (14) . Solutions of urea, mannitol, arabinose, and similar substances have been utilized to open the blood-brain barrier to Evan blue dye and other compounds that are normally excluded from cerebrospinal fluid (CSF) and brain tissue. The passage of hyperosmolar solutions through the carotid circuit appears to leech out intracellular water from cerebrovascular endothelial cells, causing them to shrink. This shrinkage widens the tight junctions between cells, which in turn disrupts their barrier function. The effect of one intracarotid injection lasts several hours, after which time the integrity of the barrier is completely restored. Clinical evaluation of the animals involved in these experiments and histological-examination of their brains have, for the most part, failed to detect any harmful or lasting effects from the intracarotid infusions.
The potential applications of this technique in (4) . This helmet allowed fixation of the head of the animal in a modified stereotaxic frame for cisternal puncture. On the day of each experiment, rabbits received a 50-mg dose of sodium pentobarbital administered intravenously via a marginal ear vein. Polyethylene catheters were then inserted into the femoral artery and vein. A solution of 0.9%o sodium chloride was continuously administered through the femoral venous catheter, which was used for anesthesia maintenance, gentamicin administration, and, in some cases, mannitol administration. The femoral arterial catheter was periodically flushed with heparinized saline to maintain patency; blood specimens for assays to measure antibiotic concentration in serum were collected from this catheter.
Rabbits were further prepared with the placement of catheters into the right common carotid artery. Atropine sulfate (0.1 mg) was administered intramuscularly before carotid artery manipulation to counteract the effects of vagal stimulation. After the right common carotid artery was isolated, a ligature was placed distal to the origin of the internal carotid artery to occlude the externalicarotid artery. Thus, the catheter inserted into the common carotid artery below this ligature provided direct access to the right internal carotid artery. This was confirmed by demonstration of retinal blanching when the carotid catheter was flushed with 0.5 ml of 0.9%v saline.
Immediately after catheter placement, gentamicin was administered intravenously. Then, animals were randomly assigned to one of the following experimental groups: (i) the intravenous saline group received an 8-mi infusion of 0.9%o saline through the femoral venous catheter over 40 s; (ii) the intracarotid saline group received an 8-ml infusion of 0.9%o saline through the common carotid catheter over 40 s; (iii) the intravenous mannitol group received an 8-ml infusion of a 2 molal mannitol solution through the The mean value for this group, 5.3 ,ug/ml, was twice that observed in the three control groups; these group differences were highly significant (H = 12.4; 0.01 > P > 0.005). Individual comparisons of one group with another established a statistically significant difference between gentamicin concentrations in CSF in the intracarotid mannitol group and the intravenous saline group, but the other individual comparisons did not reveal statistically significant differences. There was some overlap in gentamicin concentrations in CSF among animals in the four groups. Gentamicin concentrations in CSF ranged from 1.2 to 10 ,ug/ml in the intracarotid mannitol group, from 0.7 to 5.2 ,ug/ml in the intravenous mannitol group, from 0.6 to 4.6 ,ug/ml in the intracarotid saline group, and from <0.5 to 3.1 ,ug/ml in the intravenous saline group.
Gentamicin concentrations in brain tissue were also highest in animals in the intracarotid mannitol group. The mean value for this group, 2.3 ,ug/g, was almost twice that for detectable concentrations in the other groups. These group differences were highly significant (H = 23.9; P < 0.0005). Individual comparisons of one group with another also established statistically significant differences between gentamicin concentrations in brain tissue of animals in the intracarotid mannitol group and each of the three control groups. As with gentamicin concentrations in CSF, there was some overlap in concentrations in brain tissue among animals in the four groups. DISCUSSION In this study, three control groups were used to differentiate the relative contributions of the hyperosmolar solution and the intracarotid infusion. From the results, it seems clear that intracarotid infusion of the hyperosmolar solution is essential for disruption of the blood-brain barrier. Neither intracarotid infusion of normal saline nor intravenous administration of mannitol were sufficient to increase gentamicin concentrations in CSF and brain tissue. (10) . Last, the evaluation of the potential of this technique will need to address the toxic potential of high antibiotic concentrations in CSF and the brain. The neurotoxic potential of penicillin has been appreciated for some time (8) . The neurotoxicity of aminoglycoside antibiotics was first noted in early experiences with intrathecal streptomycin administration (18) . Several fatalities were reported in patients who received large intrathecal doses. In time, it became apparent that only dosages of <100 mg could be safely administered intrathecally to adult patients. More recently, neurotoxicity has been ascribed to gentamicin. A case report and experimental study have described the development of brain lesions after prolonged exposure to high gentamicin concentrations in CSF (17) . The ototoxicity of gentamicin makes evaluation of vestibular and auditory function of prime importance too. Does the osmotic disruption technique increase perilymph or endolymph aminoglycoside concentrations? Will it hasten hair cell loss in the organ of Corti? Future evaluations of osmotic disruption will need to focus on these potential toxicities as well as on those toxicities inherent in the technique itself.
